Controlled release drug delivery offers significant market opportunities by optimizing therapeutic effects and patient ...

U.S. market projected to grow from USD 2.45 billion in 2025 to USD 5.01 billion by 2035, while Europe is forecast to reach USD 4.02 billion amid rising adoption of transdermal therapeutics and vaccine ...

The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...

Controlled release systems deliver medication and other bioactive compounds to the ideal spot inside a body and over a specific time. New research from the University of Arkansas and the University of ...

Upon administration, VLPs are uptake by APC, like dendritic cells. VLPs can be presented by MHC-I or MHC-II, which are recognized by CD8+ and CD4+ T cells, respectively. For cellular response, CD8+ ...

Photopharmacology combines light and drug action, offering reversible control over biological pathways, transforming ...

VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery sys ...

Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a cell’s surface, decides whether the cell is cancerous, and then floods it ...